
Pascal Soriot
Vermögen: 71 Mio $ am 28.02.2026

Vermögen: 71 Mio $ am 28.02.2026
Derzeit ist Pascal Soriot Chief Executive Officer & Executive Director bei AstraZeneca Plc und Vorsitzender von AstraZeneca AB (einer Tochtergesellschaft von AstraZeneca Plc). Er ist auch im Vorstand von Pharmaceutical Research & Manufacturers of America und Acerta Pharma BV. Pascal Soriot war zuvor Manager-District Sales bei Roussel NZ Ltd, Director & Chief Executive Officer-Roche Group bei Genentech, Inc, Chief Operating Officer von Roche Pharmaceuticals, Inc, Chief Operating Officer bei Sanofi-Aventis U.S. LLC und Vice President-Asia Pacific bei Hoechst Marion Rousel JP. Er erwarb einen MBA an der cole des Hautes tudes Commerciales de Paris und einen Doktortitel an der cole Nationale Vtrinaire d'Alfort.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ASTRAZENECA PLC 0,02 % | 05.03.2026 | 337.102 ( 0,02 % ) | 70 Mio $ | 28.02.2026 |
| 19.03.2026 | 2.683 ( 0 % ) | 325 663 $ | 28.02.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| ASTRAZENECA PLC | Vorstandsvorsitzender | 01.10.2012 |
| AGILENT TECHNOLOGIES, INC. | Direktor/Vorstandsmitglied | 20.05.2025 |
Acerta Pharma BV
Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Develops drugs for oncology and autoimmune diseases | Direktor/Vorstandsmitglied | - |
AstraZeneca Colombia SAS | Vorstandsvorsitzender | 01.10.2012 |
AstraZeneca Österreich GmbH
AstraZeneca Österreich GmbH BiotechnologyHealth Technology Develops, produces and markets medicines for treatment of cardiovascular, metabolic, oncology, respiratory, infectious and autoimmune diseases | Vorstandsvorsitzender | - |
AstraZeneca UK Ltd.
AstraZeneca UK Ltd. Miscellaneous Commercial ServicesCommercial Services Manufactures pharmaceutical products | Vorstandsvorsitzender | - |
AstraZeneca Holding GmbH
AstraZeneca Holding GmbH Financial ConglomeratesFinance Functions as an investment holding company | Vorstandsvorsitzender | - |
AstraZeneca Pharmaceuticals LP
AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceuticals | Vorstandsvorsitzender | - |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Direktor/Vorstandsmitglied | - |
| ░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░ | - |
| Unternehmen | Position | Ende |
|---|---|---|
| ░░░ ░░░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░ ░░░░ | ░░░░░░░░ ░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░ ░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 21 |
|---|---|
Genentech, Inc.
Genentech, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
AstraZeneca PLC
AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Agilent Technologies, Inc.
Agilent Technologies, Inc. Medical SpecialtiesHealth Technology Engages in life sciences, diagnostics and applied chemical markets | Health Technology |
CSL Ltd.
CSL Ltd. BiotechnologyHealth Technology Develops and manufactures medicines that treat people with rare and serious diseases | Health Technology |
Roche Pharmaceuticals, Inc.
Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development services | Commercial Services |
Chugai Pharmaceutical Co., Ltd.
Chugai Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Operates as a holding company whose subsidiaries manufactures & sells pharmaceutical products | Health Technology |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products | Commercial Services |
AstraZeneca Pharmaceuticals LP
AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceuticals | Health Technology |
École des Hautes Études Commerciales de Paris
École des Hautes Études Commerciales de Paris Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AstraZeneca UK Ltd.
AstraZeneca UK Ltd. Miscellaneous Commercial ServicesCommercial Services Manufactures pharmaceutical products | Commercial Services |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Health Technology |
Sanofi-Aventis U.S. LLC
Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Develops medicines, vaccines and provides specialized healthcare & clinical trail services | Health Technology |
Hoechst Marion Rousel JP
Hoechst Marion Rousel JP Miscellaneous Commercial ServicesCommercial Services Conducts medical research | Commercial Services |
AstraZeneca Österreich GmbH
AstraZeneca Österreich GmbH BiotechnologyHealth Technology Develops, produces and markets medicines for treatment of cardiovascular, metabolic, oncology, respiratory, infectious and autoimmune diseases | Health Technology |
AstraZeneca Colombia SAS | |
AstraZeneca Holding GmbH
AstraZeneca Holding GmbH Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Roussel NZ Ltd. | |
École Nationale Vétérinaire d'Alfort
École Nationale Vétérinaire d'Alfort Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Acerta Pharma BV
Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Develops drugs for oncology and autoimmune diseases | Health Technology |
Viela Bio, Inc.
Viela Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biotechnology company that develops treatments for severe inflammation and autoimmune diseases | Health Technology |
The Sustainable Markets Initiative |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
MarketScreener is also available in this country: United States.
Switch edition